Related Experiment Video
Updated: Dec 26, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
[Lung cancer in Eastern Morocco: where do we stand?]
Karam Yahya Belmokhtar1, Mariam Tajir1, Redouane Boulouiz1
1Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco.
Lung cancer in Eastern Morocco affects younger individuals and is diagnosed late, with limited access to molecular testing. Effective lung cancer programs and improved access to molecular tests and therapies are needed.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Lung cancer is a significant health concern in Eastern Morocco, particularly among men.
- This study provides the first comprehensive report on lung cancer characteristics in this region.
Purpose of the Study:
- To describe the clinical, pathological, and therapeutic features of lung cancer in Eastern Morocco.
- To highlight disparities in diagnosis and treatment compared to Western countries.
Main Methods:
- A retrospective study of 738 lung cancer patients diagnosed between 2005 and 2014.
- Analysis of patient demographics, smoking status, age at diagnosis, and treatment modalities.
Main Results:
- The majority of patients were male smokers diagnosed at an advanced stage.
- A notable proportion of younger patients (<50 years) presented with adenocarcinoma and higher cannabis use.
- Access to molecular testing and targeted therapies was severely limited.
Conclusions:
- Lung cancer in Eastern Morocco is characterized by late diagnosis and affects a younger demographic.
- There is a critical need for enhanced lung cancer screening programs and improved access to diagnostic and therapeutic innovations.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cancer
Statistical Methods for Analyzing Epidemiological Data
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

